Literature DB >> 32228331

Comparative analysis of electrocardiographic imaging and ECG in predicting the origin of outflow tract ventricular arrhythmias.

Xinbin Zhou1, Lin Fang2, Zhijun Wang1, Huafeng Liu2, Wei Mao1.   

Abstract

Entities:  

Keywords:  12-lead electrocardiogram algorithms; Non-invasive mapping; catheter ablation; electrocardiographic imaging; left ventricular outflow tract; outflow tract ventricular arrhythmias; right ventricular outflow tract

Mesh:

Year:  2020        PMID: 32228331      PMCID: PMC7132561          DOI: 10.1177/0300060520913132

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


× No keyword cloud information.

Introduction

Idiopathic outflow tract ventricular arrhythmias (OTVAs), which are mainly premature ventricular contractions (PVCs) and ventricular tachycardia (VT), are the most common types of arrhythmias and are usually present without structural heart disease.[1] Frequent OTVA may cause left ventricular dysfunction and even heart failure.[2] Radiofrequency catheter ablation (RFCA) is a safe and effective therapy for idiopathic OTVA.[3] Therefore, it is important to precisely predict the origin of OTVA to define the appropriate strategy and approach before the ablation procedure. Conventional 12-lead electrocardiograms (ECGs) have been a useful tool for analyzing cardiac arrhythmias, and numerous ECG algorithms for predicting the origin of OTVA have been reported.[4-12] However, because of the limited number of electrodes on the body surface, accurate localization of the OTVA origin is limited. This limitation may influence the efficiency and outcome of ablation therapy. Electrocardiographic imaging (ECGI) is a novel three-dimensional, non-invasive technique for mapping the epicardial electrical activity of the heart.[13] It has the advantage of being able to provide global chamber mapping in a single PVC beat, which suggests its potential role in exploring various cardiac arrhythmias. The objectives of our study are as follows: first, to compare the accuracy of non-invasive ECGI in estimating the origin of OTVAs with that of conventional ECG algorithms; and second, to directly compare the efficiency of all the proposed 12-lead ECG algorithms in the localization and sublocalization of the OTVA origin.

Methods

Study population

Patients with symptomatic or asymptomatic but frequent (>10,000 per 24 hour) monomorphic PVCs/VT and who were undergoing catheter ablation were prospectively recruited. The exclusion criteria were as follows: (1) failure or abandonment of the ablation procedure; (2) severe cardiac dysfunction; (3) patients with complications including other severe diseases (e.g., hepatic and renal dysfunction, malignant tumor) or contraindications for ablation; and (4) pregnancy. Informed consent was obtained from each participant who was included in the study. All procedures that involved human participants were conducted in accordance with the ethical standards of the institutional research committee (Approved by the Ethic Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University, 15 May 2018) and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Electrocardiographic imaging methods

The computational methods that are used for ECGI have already been described and validated.[13,14] Briefly, a 64-electrode vest was applied in our study to the patient’s torso for 5 minutes to record surface potentials, and this was followed by a thoracic computed tomography (CT) scan to construct the three-dimensional heart model from the outline of the heart surface that was extracted from the CT slices. The torso model was created by matching the 64-electrode positions to a standard torso template with 235 triangles of Delaunay triangulation.[15] The mathematical method of the ECGI procedure was also described in our previous study.[15] Briefly, a novel framework based on low-rank and sparse decomposition (LSD) + total variation (TV) was proposed to reconstruct the cardiac electrical activity of PVCs/VT based on the surface potential data and geometrical information. The origin of the PVCs/VT was then prospectively localized via the reconstructed cardiac potential maps.

Twelve-lead ECG algorithms

Seven 12-lead ECG algorithms were selected to compare the accuracy of predicting the origin of OTVAs. All the proposed 12-lead ECG algorithms are summarized in Table 1. Briefly, all the algorithms localize the origin to either the left ventricular outflow tract (LVOT) or the right ventricular outflow tract (RVOT), and the algorithms published by Zhang et al.[12] and Ito et al.[7] provide additional criteria for further sublocalization within the RVOT (septum vs. free-wall). The analysis was retrospectively performed by two electrophysiologists using each of the proposed algorithms to identify the origin. Both the examiners were blinded to the previously established diagnosis, ECGI data, and ablation outcomes. Disagreements between the two examiners were resolved by a third electrophysiologist based on the majority rule principle. The interobserver variability was also tested. To directly compare the performance between ECGI and 12-lead ECG, the exclusive diagnosis for each patient in whom there was a differentiation between the RVOT and the LVOT was also established based on the seven ECG algorithms and the majority rule principle. To compare the sublocalization values within the RVOT between the two ECG algorithms and ECGI, only patients who were diagnosed as having the origin in the RVOT using an electrophysiological (EP) study were further analyzed.
Table 1.

Published 12-lead ECG algorithms to localize the origin of OTVAs.

AuthorsYearECG criteria
Cheng[5]2013(1) R-wave deflection interval in lead V3 >80 ms predicts the origin site in LVOT;(2) R-wave deflection interval in lead V3 ≤80 ms and the R-wave amplitude index in lead V1 >0.3 predict the origin site in the LVOT, otherwise it is located in the RVOT
Betensky[4]2011(1) R/S transition later than the sinus rhythm transition predicts an RVOT origin; (2) V2 transition ratio (defined as percentage R-wave during PVC/VT divided by the percent R-wave in SR) ≥0.6 predicts an LVOT origin
Zhang[12]2009(1) LBBB morphology inferior axis indicates an RVOT origin; (2) transitional zone ≥V4 predicts an RVOT origin; (3) R-wave duration index <0.5 or the R/S wave amplitude index <0.3 in V1/V2 predicts an RVOT origin; (4) RRʹ or RSRʹ pattern in lead aVL predicts an origin near the bundle of His region; (5) PVC-QRS duration/sinus beat QRS duration ≥1.9 predicts an origin in the free wall of the RVOT, otherwise it is located in the septum of RVOT
Ito[7]2003(1) S-wave ≥0.1 mV in V6 predicts the origin in the LV endocardium; (2) S-wave <0.1 mV, transition zone <V4 or no S-wave in I, R-wave duration index  <0.5, and the R/S wave amplitude index <0.3; and   (a) S-wave in lead I identifies the origin in the septum of RVOT;   (b) R or RRʹ in lead I and RSRʹ or RRʹ in aVL predicts the origin near the bundle of His region;   (c) RRʹ in lead I and the inferior leads and an S-wave amplitude ≥3 mV in     V2 predicts the origin in the RVOT free wall; (3) transition zone <V4 and R/S amplitude index >0.3 or R-wave duration index >0.5 and Q-wave: aVL/aVR <1.4 mV and S-wave ≤1.2 mV in V1 predicts a left sinus Valsalva origin;
Yoshida[11]2014V2S/V3R index ≤1.5 predicts an LVOT origin, otherwise it is an RVOT origin;
Ouyang[9]2002LBBB morphology, inferior axis; and R-wave duration index (defined as a percentage by dividing the QRS complex duration by the longer R-wave duration) ≥50% and R/S amplitude index (greater value for the R/S wave amplitude ratio) ≥30% in leads V1, V2 predicts an aortic sinus cusp origin;
Yoshida[10]2011The transitional zone (TZ) index (defined as TZ score of OTVA − TZ score of sinus beat) <0 predicts an ASC origin, otherwise it is an RVOT origin.

RVOT, right ventricular outflow tract; LVOT, left ventricular outflow tract; OTVA, outflow tract ventricular arrhythmia; PVC/VT, premature ventricular contraction/ventricular tachycardia; LBBB, left bundle branch block; ASC, aortic sinus cusps.

Published 12-lead ECG algorithms to localize the origin of OTVAs. RVOT, right ventricular outflow tract; LVOT, left ventricular outflow tract; OTVA, outflow tract ventricular arrhythmia; PVC/VT, premature ventricular contraction/ventricular tachycardia; LBBB, left bundle branch block; ASC, aortic sinus cusps.

Electrophysiological study and ablation

All patients underwent an invasive EP procedure. Antiarrhythmic drugs were discontinued at least 48 hours before the invasive EP study. The invasive EP study was guided by the Ensite NavX/Velocity mapping system (St. Jude Medical, Saint Paul, MN, USA). Depending on the suspected location of the OTVAs (RVOT or LVOT), one 7F vascular sheath was inserted into the right femoral vein or 8F vascular sheath was inserted into the right femoral artery after local anesthesia. A standard irrigated-tip therapy Cool Path Duo ablation catheter (St. Jude Medical) was applied. Power delivery ranged from 30 to 40 W with a maximum temperature limited to 60°C for the RVOT and the LVOT. Left-sided mapping was performed via the retrograde transaortic approach with systemic heparinization under the targeted activated clotting time of >250 seconds. Acute ablation success was defined as no recurrence of spontaneous or induced PVCs/VT within 30 minutes after the last ablation with or without isoprenaline infusion.

Statistical analysis

Data analysis was performed using IBM SPSS Statistics for Windows (version 20.0; IBM Corp., Armonk, NY, USA). Continuous variables are presented as the mean ± standard deviation (SD). Categorical variables are expressed as counts and percentages. Baseline characteristics were compared using the χ2 test for categorical variables and the Mann–Whitney U test for continuous variables. The differences in the accuracies between the ECGI and ECG algorithms and those for the seven ECG algorithms were evaluated using McNemar’s tests. Kappa coefficients were also calculated to assess the interobserver agreement for all seven ECG algorithms. Kappa values ≥0.75 were considered to represent adequate agreement. A p value <0.05 was considered to be statistically significant.

Results

Patient characteristics

Twenty-seven patients with OTVAs were enrolled into this study. Patient clinical characteristics are summarized in Table 2. Acute procedural successes were achieved for all the included patients. Ablation was delivered at 22 RVOT sites, including 19 RVOT septum sites, three RVOT free wall sites, and five LVOT sites. Based on the successful PVCs/VT ectopy ablation site, the patients were divided into the RVOT group or the LVOT group.
Table 2.

Patients’ clinical characteristics.

RVOT (n = 22)LVOT (n = 5) p
Age (years; mean ± SD)49 ± 1542 ± 210.419
Female/Male (n)8/142/30.629
PVC frequency (per 24 hours; mean ± SD)29415 ± 1028718719 ± 33410.171
PVC burden (%; mean ± SD)27 ± 1018 ± 40.228
LVEF (%; mean ± SD)69.1 ± 11.573.7 ± 1.80.597
LVIDd (mm; mean ± SD)50.0 ± 4.550.7 ± 5.90.845
LVIDs (mm; mean ± SD)30.0 ± 5.228.9 ± 2.40.772
LAd (mm; mean ± SD)35.2 ± 4.645.2 ± 5.70.014
Use of antiarrhythmic drugs (%)7/22 (31.8%)2/5 (40.0%)0.553
History
 Coronary heart disease (%)0/22 (0%)0/5 (0%)
 Cardiomyopathy (%)1/22 (4.5%)0/5 (0%)0.815
 Hypertension (%)5/22 (22.7%)2/5 (40%)0.580

RVOT, right ventricular outflow tract; LVOT, left ventricular outflow tract; PVC, premature ventricular contraction; LVEF, left ventricular ejection fraction; LVIDd, left ventricular internal dimension diastole; LVIDs, left ventricular internal dimension systole; LAd, left atrial diameter; SD, standard deviation.

Patients’ clinical characteristics. RVOT, right ventricular outflow tract; LVOT, left ventricular outflow tract; PVC, premature ventricular contraction; LVEF, left ventricular ejection fraction; LVIDd, left ventricular internal dimension diastole; LVIDs, left ventricular internal dimension systole; LAd, left atrial diameter; SD, standard deviation.

Localization accuracy of ECGI and comparison with the 12-lead ECG algorithms

All clinical PVCs/VT were recorded before the EPS and ablation procedure by the ECGI system, and the 3D electroanatomic maps were reconstructed for all patients, which were then applied to localize the origin of OTVA ectopy (Figure 1).
Figure 1.

ECGI map of PVCs that originated from the RVOT septum and its comparison with the successful site of ablation.

(a) A representative ECGI reconstructed potential map of RVOT septum ectopy (patient 13). A1 and A2 show different views of the reconstructed heart model. A1 represents the PA+CRA view and A2 represents the LL+CRA view. The white solid line represents the free wall and the white dotted line represents the septum in A1–2. The red region in A1–2 represents the initial breakthrough site in the RVOT septum and early activation towards the right side. A3 shows the surface 12-lead ECG from the same patient. The time instant of the displayed potential maps in A1–2 is assigned by the vertical line in the ECG signals in A3.(b) Successful ablation site in the Ensite Velocity mapping system during the procedure. B1 shows the LL view; B2 shows the RL view, and the white star represents the successful ablation site.

LVOT, left ventricular outflow tract; RVOT, right ventricular outflow tract; SEP, septum; FW, free wall; PA, posterior anterior; CRA, cranial; LL, left lateral; RL, right lateral.

ECGI map of PVCs that originated from the RVOT septum and its comparison with the successful site of ablation. (a) A representative ECGI reconstructed potential map of RVOT septum ectopy (patient 13). A1 and A2 show different views of the reconstructed heart model. A1 represents the PA+CRA view and A2 represents the LL+CRA view. The white solid line represents the free wall and the white dotted line represents the septum in A1–2. The red region in A1–2 represents the initial breakthrough site in the RVOT septum and early activation towards the right side. A3 shows the surface 12-lead ECG from the same patient. The time instant of the displayed potential maps in A1–2 is assigned by the vertical line in the ECG signals in A3.(b) Successful ablation site in the Ensite Velocity mapping system during the procedure. B1 shows the LL view; B2 shows the RL view, and the white star represents the successful ablation site. LVOT, left ventricular outflow tract; RVOT, right ventricular outflow tract; SEP, septum; FW, free wall; PA, posterior anterior; CRA, cranial; LL, left lateral; RL, right lateral. The OTVA chamber was correctly identified in 27/27 (100%) patients and the sublocalization within the RVOT was achieved in 21/22 (95.5%) patients using the ECGI procedure. The sensitivity and specificity were both 1.00 for ECGI for differentiating between RVOT origins and LVOT origins, and these parameters were 0.95 and 1.00 for sublocalization of the septum and free-wall, respectively, within the RVOT. For 20/27 patients who had a V3 transition in the ECG, the OTVA chamber was correctly diagnosed in 20/20 (100%) patients and the sublocalization was also correctly diagnosed within the RVOT in 19/20 (95.0%) patients using the ECGI method. One failed sublocalization (patient 22) in the ECGI group predicted an origin site in the RVOT free wall, but the OTVA was ablated successfully at the RVOT septum. However, compared with the ECGI procedure, the chamber was correctly identified in only 21/27 (77.8%) patients (p = 0.041) and the sublocalization was correctly localized in 13/22 (59.1%) patients (p = 0.027) using the ECG algorithm (Table 3).
Table 3.

Localization accuracy of ECGI and comparison with that of 12-lead ECG algorithms.


12-lead ECG localization

ECGI localization
PatientEPSEctopy originSub-localizationEctopy originSub-localization p
1RVOT sepRVOTsepRVOTsep
2RVOT sepRVOTfwRVOTsep
3LVOTLVOTLVOT
4RVOT sepLVOTfwRVOTsep
5RVOT sepRVOTsepRVOTsep
6RVOT sepRVOTsepRVOTsep
7RVOT sepRVOTfwRVOTsep
8RVOT fwRVOTfwRVOTfw
9RVOT sepLVOTsepRVOTsep
10LVOTLVOTLVOT
11RVOT sepRVOTfwRVOTsep
12LVOTRVOTLVOT
13RVOT sepRVOTsepRVOTsep
14RVOT sepLVOTfwRVOTsep
15RVOT fwRVOTsepRVOTfw
16RVOT sepRVOTsepRVOTsep
17RVOT fwRVOTsepRVOTfw
18RVOT sepRVOTfwRVOTsep
19RVOT sepRVOTsepRVOTsep
20LVOTLVOTLVOT
21RVOT sepRVOTsepRVOTsep
22RVOT sepRVOTsepRVOTfw
23RVOT sepLVOTsepRVOTsep
24RVOT sepRVOTsepRVOTsep
25RVOT sepRVOTsepRVOTsep
26LVOTLVOTLVOT
27RVOT sepLVOTfwRVOTsep
Accuracy(%)21/27(77.8%)27/27(100%)0.041
13/22(59.1%)21/22(95.5%)0.027

EPS, electrophysiological study; RVOT, right ventricular outflow tract; LVOT, left ventricular outflow tract; sep, septum; fw, free wall; ECG, electrocardiography; ECG, electrocardiographic imaging.

Localization accuracy of ECGI and comparison with that of 12-lead ECG algorithms. EPS, electrophysiological study; RVOT, right ventricular outflow tract; LVOT, left ventricular outflow tract; sep, septum; fw, free wall; ECG, electrocardiography; ECG, electrocardiographic imaging. In addition, the receiver operating characteristic (ROC) curve analysis regarding the predictive value of ECGI and the seven ECG algorithms for differentiating the LVOT from the RVOT arrhythmias was conducted. The results showed a similar diagnostic accuracy among the seven ECG algorithms, with areas under the curve (AUCs) ranging from 0.69 to 0.86, but there was a significantly higher accuracy for ECGI, which had an AUC of 1.00 (p < 0.05; Figure 2).
Figure 2.

ROC analysis for the predictive value of ECGI and seven ECG algorithms for differentiating between the RVOT and the LVOT.

ROC, receiver operating characteristic; LVOT, left ventricular outflow tract; RVOT, right ventricular outflow tract.

ROC analysis for the predictive value of ECGI and seven ECG algorithms for differentiating between the RVOT and the LVOT. ROC, receiver operating characteristic; LVOT, left ventricular outflow tract; RVOT, right ventricular outflow tract.

Comparison of the predictive value of the seven 12-lead ECG algorithms for differentiating between the RVOT and LVOT

The seven ECG algorithms were assessed for their diagnostic accuracy, specificity, sensitivity, and likelihood ratios (LRs) of differentiating between the RVOT and LVOT to determine the origin of PVCs/VT. The results are summarized in Table 4. Assessment of the diagnostic accuracy showed that each of the seven algorithms had only moderate accuracy, and the greatest accuracy was observed in the algorithm proposed by Yoshida[10]. However, when the algorithms were compared for their accuracy, specificity, sensitivity, and LRs, no significant differences were found.
Table 4.

Overall diagnostic accuracy of seven 12-lead ECG algorithms for differentiating the RVOT from the LVOT, and the specificity, sensitivity, positive and negative likelihood ratios for differentiation.

ChengBetenskyZhangItoYoshida, 2014OuyangYoshida, 2011 p
Accuracy (%)77.874.185.285.277.881.588.9>0.05
Specificity (%)80.060.080.080.080.080.080.0>0.05
Sensitivity (%)77.377.386.486.477.381.890.9>0.05
LR(+)3.861.934.324.323.864.094.55
LR(−)0.280.380.170.170.280.230.11

LR(+), positive likelihood ratios; LR(−), negative likelihood ratios.

Overall diagnostic accuracy of seven 12-lead ECG algorithms for differentiating the RVOT from the LVOT, and the specificity, sensitivity, positive and negative likelihood ratios for differentiation. LR(+), positive likelihood ratios; LR(−), negative likelihood ratios. The interobserver agreement between the two independent electrophysiologists in localizing between the RVOT and LVOT was calculated for all the ECG algorithms. The algorithm published by Yoshida[10] had the highest kappa value of 1.00, and acceptable kappa values of 0.886 and 0.836 were obtained for algorithms proposed by Yoshida[11] and Ouyang[9], respectively. However, poor interobserver agreements, with kappa values ranging from 0.625 to 0.697, were detected for algorithms proposed by Cheng,[5] Betensky,[4] Zhang[12], and Ito[7] (Table 5).
Table 5.

Interobserver agreements between ECG algorithms.


Interobserver agreements of assessors for differentiating the RVOT from the LVOT
ChengBetenskyZhangItoYoshida, 2014OuyangYoshida, 2011
Kappa0.6250.6970.6250.6250.8860.8361.000
p 0.0000.0000.0010.0010.0000.0000.000

Sublocalization within the RVOT: septum vs. free wall

Zhang

Ito
Kappa0.2520.636
p 0.2110.003

RVOT, right ventricular outflow tract; LVOT, left ventricular outflow tract.

Interobserver agreements between ECG algorithms. RVOT, right ventricular outflow tract; LVOT, left ventricular outflow tract.

Sublocalization within the RVOT: Septum vs. free wall

The ECG algorithms proposed by Zhang et al.[12] and Ito et al.[7] provide criteria for sublocalization of the origin in the RVOT septum compared with the RVOT free wall. The accuracy of the ECG algorithm proposed by Zhang et al.[12] was significantly higher compared with that proposed by Ito et al.[7], and there were significant differences in specificity, sensitivity, and positive and negative LRs between these two algorithms (p = 0.039) (Table 6). However, poor interobserver agreement was detected for the algorithm by Zhang[12], which had a kappa value of 0.252, and this is much lower compared with the algorithm by Ito[7] (kappa value, 0.636) (Table 5).
Table 6.

Accuracy, specificity, sensitivity, positive, and negative likelihood ratios of two ECG algorithms in sublocalization within the RVOT: septum vs. free wall.

ZhangIto p [a]
Accuracy (%)72.740.90.039
Specificity (%)66.733.3
Sensitivity (%)73.742.1
LR(+)2.210.63
LR(–)0.391.74

aMcNemar’s test.

LR(+), positive likelihood ratios; LR(−), negative likelihood ratios; RVOT, right ventricular outflow tract; ECG, electrocardiography.

Accuracy, specificity, sensitivity, positive, and negative likelihood ratios of two ECG algorithms in sublocalization within the RVOT: septum vs. free wall. aMcNemar’s test. LR(+), positive likelihood ratios; LR(−), negative likelihood ratios; RVOT, right ventricular outflow tract; ECG, electrocardiography.

Discussion

The results of our study showed that non-invasive ECGI had better accuracy compared with that of the conventional 12-lead ECG algorithm for identifying the origin of OTVAs.

Comparison of the seven different ECG algorithms in localizing the origin of OTVAs

In the “head-to-head” comparison, all the seven published 12-lead ECG algorithms for OTVA differentiation were similar in terms of the diagnostic accuracy, specificity, sensitivity, and LRs. The predicted accuracy of the ECG algorithms in our study ranged from 74.1% to 88.9%, the specificity ranged from 60% to 80%, and the sensitivity ranged from 77.3% to 90.9%, all of which were lower compared with results that were previously reported by their authors.[4,5,7,9-12] Possible explanations for the lack of reproducibility may be the differences in the population and the heterogeneity between the assessors in the present study and the developers of a particular algorithm because four of the seven ECG algorithms exhibited poor interobserver agreement. To the best of our knowledge, the specificity, sensitivity, and LRs of the published ECG algorithms for determining the OTVA origin have not been tested in a “head-to-head” comparison. The positive and negative LRs of a particular algorithm that is used to diagnose the OTVA origin may have clinical value by providing a comprehensible measurement of the strength that is required to reach a diagnosis.[16] Recently, some new algorithms were also proposed, such as the QRS morphology pattern in V5R,[12] synthesized right-sided chest lead electrocardiography,[8] and the QRS-RVA interval during an electrophysiology study,[17] all of which focused on parameters that are beyond the conventional 12-lead ECG algorithm and provide more tools to help physicians reach an accurate diagnosis. Two ECG algorithms in our study provide further criteria for sublocalization of the RVOT septum compared with the RVOT free wall. The ECG algorithm proposed by Zhang et al.[12] was found to be superior to that proposed by Ito et al.[7] in terms of the specificity, sensitivity, LR(+), and LR(−). However, the algorithm proposed by Zhang et al.[12] exhibits a significantly low kappa value of 0.252, suggesting poor interobserver agreement. The accuracy of both algorithms was lower in our study compared with that in its origin study[7,12] and in studies that were recently published on differentiating between the origin sites within the RVOT.[16,18] Thus, the results should be interpreted with caution.

Limitations of the ECG algorithms and conventional mapping methods

There are some limitations that are associated with using the 12-lead ECG algorithms that were found in this study or reported in previous studies.[8,16,19] For example, several algorithms require an accurate measurement of many ECG parameters, and thus, inconsistencies and heterogeneities between assessors may be inevitable, especially with wandering baselines, lead noise, and lack of electronic calipers.[8,16,19] The spatial relationship between the heart and torso among different patients and variable precordial lead placements could further lead to inaccuracies in ECG algorithms. In addition, in some proposed ECG algorithms, the sinus rhythm and QRS-wave that precede the PVCs/VT are essential, which could limit their clinical application. Additionally, for the algorithms of sublocalization within the RVOT, the steps to reach a certain diagnosis increased significantly, which could result in more extensive errors and heterogeneity. All the erroneous predictions of the OTVA origin that used a 12-lead algorithm may result in inappropriate ablation approaches and negatively affect its effectiveness. Some limitations of conventional mapping techniques during the procedures may also worsen the ablation outcome, including poor spatial resolution of pace mapping, in scenarios where spontaneous ectopy is infrequent, or when there is difficulty in inducing tachycardia. The newly developed invasive noncontact three-dimensional mapping systems, such as Ensite and CARTO, provide new platforms for mapping cardiac arrhythmias in three dimensions. They provide accurate visualization of the OTVA origin in a complex three-dimensional substrate, which greatly increases the success of ablation and reduces the procedure time. However, it requires systemic heparinization, even in the right ventricle, which increases the risk of bleeding complications. In addition, only a single chamber can be mapped at a time in a point-by-point manner.

Efficacy and advantages of ECGI in localizing OTVA origin and its clinical impact

ECGI had a high accuracy of 100% in chamber localization and 95.5% in sublocation within the RVOT to determine the OTVA origin. These results are similar to those in a previously published study by Jamil-Copley et al.,[19] which assessed the performance of electrocardiographic mapping in locating the origin of outflow tract ventricular tachycardia using the Tikhonov regularization method and the generalized minimal residual iterative technique. However, we proposed a novel mathematical method for ECGI and directly compared the performance of ECGI with that of seven published ECG algorithms, demonstrating the superiority of ECGI. For patient 22, the ECGI system suggested an OTVA origin in the RVOT free wall, but the ablation site was in the RVOT septum. These two locations are quite close to each other. This incorrect result may be caused by the ill-posed nature of the spatiotemporal ECG-inverse problem in ECGI using our improved potential-based method. Thus, the potential-to-activation transformation method should be further optimized in our mapping algorithm to improve its accuracy. Because ECGI is a unique method and each patient’s own heart–torso model is used, the limitations of the 12-lead ECG that result from individual variability and variable lead placement could be addressed to some extent, especially for patients who had a V3 transition in the ECG and underlying structural cardiac abnormalities. ECGI can localize the PVC origin within only one heartbeat, and both ventricles can be mapped simultaneously, exhibiting its advantage in mapping infrequent OTVA. Additionally, it is a non-invasive method that could be a useful tool to study the mechanisms of various complicated arrhythmias such as atrial fibrillation. The ECGI system could also contribute to planning the ablation strategy regarding the appropriate arterial or venous vascular access, which may reduce the risk of complications. Additionally, the high accuracy of ECGI can greatly simplify the mapping process, potentially reduce the procedural and fluoroscopic time, and improve clinical outcomes, resulting in greater clinical utility. Some limitations should be noted. First, complete predictive accuracy should not be expected because ECGI is still in the early stages of development. Second, the increased overall radiation exposure should be taken into account because CT scanning is currently required for the system, and this should be weighed against all the benefits. Cardiac magnetic resonance imaging (MRI) could replace CT scanning in the future, which may further reduce CT-related high radiation exposure. Finally, ECGI mainly provides the epicardial activation maps, but they are not always identical to the endocardial activation maps. To directly compare the ECGI and ECG performance, the localizing ability of ECGI was limited to left ventricle or to two segments in the right ventricle, and the precise site was not further assessed. The small patient group in our study may, to some extent, affect the results of both the comparison among 12-lead ECG algorithms and between ECG algorithms and ECGI in predicting the OTVA origin because not all the possible ectopies were included, especially those from the aortic sinus cusps or epicardium, and only five patients with a LVOT origin were included. However, non-invasive ECGI was still shown to have good accuracy and better performance compared with the 12-lead ECG algorithms, especially in patients with symptomatic but infrequent OTVAs.

Conclusions

The seven published 12-lead ECG algorithms have similar and moderate accuracy in the localization of OTVA origin, while the non-invasive ECGI can accurately differentiate between the RVOT and the LVOT and between the septum and free wall in the RVOT, which outperforms the conventional 12-lead ECG.
  18 in total

1.  Novel algorithm for arrhythmogenic focus localization in patients with right ventricular outflow tract arrhythmias.

Authors:  Mariusz Pytkowski; Aleksander Maciąg; Maciej Sterliński; Agnieszka Jankowska; Ilona Kowalik; Michał M Farkowski; Rafał Kuteszko; Dariusz Zając; Bohdan Firek; Zbigniew Chmielak; Hanna Szwed
Journal:  Cardiol J       Date:  2013-08-30       Impact factor: 2.737

2.  Electrocardiographic algorithm to identify the optimal target ablation site for idiopathic right ventricular outflow tract ventricular premature contraction.

Authors:  Fengxiang Zhang; Minglong Chen; Bing Yang; Weizhu Ju; Hongwu Chen; Jian Yu; Chu-Pak Lau; Kejiang Cao; Hung-Fat Tse
Journal:  Europace       Date:  2009-09       Impact factor: 5.214

3.  Clinical utility of likelihood ratios.

Authors:  E J Gallagher
Journal:  Ann Emerg Med       Date:  1998-03       Impact factor: 5.721

4.  The V(2) transition ratio: a new electrocardiographic criterion for distinguishing left from right ventricular outflow tract tachycardia origin.

Authors:  Brian P Betensky; Robert E Park; Francis E Marchlinski; Matthew D Hutchinson; Fermin C Garcia; Sanjay Dixit; David J Callans; Joshua M Cooper; Rupa Bala; David Lin; Michael P Riley; Edward P Gerstenfeld
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

5.  A novel electrocardiographic criterion for differentiating a left from right ventricular outflow tract tachycardia origin: the V2S/V3R index.

Authors:  Naoki Yoshida; Takumi Yamada; H Thomas McElderry; Yasuya Inden; Masayuki Shimano; Toyoaki Murohara; Vineet Kumar; Harish Doppalapudi; Vance J Plumb; G Neal Kay
Journal:  J Cardiovasc Electrophysiol       Date:  2014-03-19

6.  The R-wave deflection interval in lead V3 combining with R-wave amplitude index in lead V1: a new surface ECG algorithm for distinguishing left from right ventricular outflow tract tachycardia origin in patients with transitional lead at V3.

Authors:  Zhongwei Cheng; Kang'an Cheng; Hua Deng; Taibo Chen; Peng Gao; Kongbo Zhu; Quan Fang
Journal:  Int J Cardiol       Date:  2012-12-27       Impact factor: 4.164

7.  Estimation of the origin of ventricular outflow tract arrhythmia using synthesized right-sided chest leads.

Authors:  Masahiro Nakano; Marehiko Ueda; Masayuki Ishimura; Takatsugu Kajiyama; Naotaka Hashiguchi; Tomonori Kanaeda; Yusuke Kondo; Yasunori Hiranuma; Yoshio Kobayashi
Journal:  Europace       Date:  2013-11-26       Impact factor: 5.214

8.  Development and validation of an ECG algorithm for identifying the optimal ablation site for idiopathic ventricular outflow tract tachycardia.

Authors:  Sachiko Ito; Hiroshi Tada; Shigeto Naito; Kenji Kurosaki; Marehiko Ueda; Hiroshi Hoshizaki; Isamu Miyamori; Shigeru Oshima; Koichi Taniguchi; Akihiko Nogami
Journal:  J Cardiovasc Electrophysiol       Date:  2003-12

9.  Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter study.

Authors:  Ashok J Shah; Meleze Hocini; Olivier Xhaet; Patrizio Pascale; Laurent Roten; Stephen B Wilton; Nick Linton; Daniel Scherr; Shinsuke Miyazaki; Amir S Jadidi; Xingpeng Liu; Andrei Forclaz; Isabelle Nault; Lena Rivard; Michala E F Pedersen; Nicolas Derval; Frederic Sacher; Sebastien Knecht; Pierre Jais; Remi Dubois; Sandra Eliautou; Ryan Bokan; Maria Strom; Charu Ramanathan; Ivan Cakulev; Jayakumar Sahadevan; Bruce Lindsay; Albert L Waldo; Michel Haissaguerre
Journal:  J Am Coll Cardiol       Date:  2013-05-30       Impact factor: 24.094

10.  Noninvasive electrocardiographic mapping to guide ablation of outflow tract ventricular arrhythmias.

Authors:  Shahnaz Jamil-Copley; Ryan Bokan; Pipin Kojodjojo; Norman Qureshi; Michael Koa-Wing; Sajad Hayat; Andreas Kyriacou; Belinda Sandler; Afzal Sohaib; Ian Wright; David Wyn Davies; Zachary Whinnett; Nicholas S Peters; Prapa Kanagaratnam; Phang Boon Lim
Journal:  Heart Rhythm       Date:  2014-01-17       Impact factor: 6.343

View more
  1 in total

1.  Effect of Myocardial Fiber Direction on Epicardial Activation Patterns.

Authors:  Lindsay C Rupp; Wilson W Good; Jake A Bergquist; Brian Zenger; Karli Gillette; Gernot Plank; Rob S MacLeod
Journal:  Comput Cardiol (2010)       Date:  2021-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.